No area of stroke research should be left behind

 More than 12 million incident cases of stroke are thought

to have occurred in 2019, when stroke was also the

second-leading cause of death and the third-leading cause

of death and disability combined. Thanks to the efforts of

stroke researchers and study participants, many advances

that might help to reduce this burden have been made

over the past two decades. Much of this progress has

been in acute management and secondary prevention of

ischaemic stroke, and as this issue of The Lancet Neurology

was going to press, results from several trials testing

such approaches were scheduled to be presented at the

8th European Stroke Organisation Conference (ESOC),

on May 4–6, 2022, in Lyon, France. If such progress is to

continue, and similarly impressive advances are to be

made in primary prevention, haemorrhagic stroke, and

longer-term care, all areas of stroke need to be a higher

priority for research funding.

https://drive.google.com/file/d/1eGQds8AyZjDQXgkdnjDX8UgqCWX88ZTA/view?usp=sharing